Submit your email to push it up the queue
Ecomedics S.A.S., a prominent player in the medical cannabis industry, is headquartered in Colombia (CO) and operates extensively across Latin America. Founded in 2018, the company has quickly established itself as a leader in the cultivation, processing, and distribution of high-quality cannabis products. Ecomedics focuses on developing innovative solutions for both medicinal and therapeutic applications, setting itself apart with its commitment to sustainability and rigorous quality control. With a diverse portfolio that includes oils, extracts, and other cannabis-derived products, Ecomedics S.A.S. is dedicated to advancing the medical cannabis sector. The company has achieved significant milestones, including regulatory approvals and partnerships that enhance its market position. Ecomedics continues to drive growth and innovation, making a notable impact in the evolving landscape of medical cannabis.
How does Ecomedics S.A.S.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Ecomedics S.A.S.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ecomedics S.A.S., headquartered in Colombia, currently does not have available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. The company is classified as a current subsidiary and inherits its emissions data from its parent organisation, Ecomedics S.A.S., but no specific figures or commitments have been disclosed. As a current subsidiary, Ecomedics S.A.S. does not have any publicly stated climate pledges or commitments to reduce emissions, nor does it participate in initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). The absence of emissions data and reduction targets indicates a need for further transparency and commitment to climate action within the organisation. In the context of the industry, it is essential for companies like Ecomedics S.A.S. to establish clear climate commitments and reduction strategies to align with global sustainability goals.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ecomedics S.A.S. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.